Viewing Study NCT02620020


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-02 @ 3:48 PM
Study NCT ID: NCT02620020
Status: COMPLETED
Last Update Posted: 2020-06-16
First Post: 2015-11-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain
Sponsor: Regeneron Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: R475-PN-1524
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators